Xiaoli Liang
Guangzhou Medical University
8 Papers
8 Citations
Xiaoli Liang is an academic researcher from Guangzhou Medical University. The author has contributed to research in topics: Influenza A virus & Virus. The author has an hindex of 7, co-authored 8 publications.
Chat about Author
Papers
Aurantiamide acetate from baphicacanthus cusia root exhibits anti-inflammatory and anti-viral effects via inhibition of the NF-κB signaling pathway in Influenza A virus-infected cells
Zhou Beixian,Yang Zifeng,Qi-Tong Feng,Xiaoli Liang,Jing Li,Mark Zanin,Zhi-Hong Jiang,Nanshan Zhong,Nanshan Zhong +8 more
TL;DR: Results indicate that compound E17 isolated from B. cusia root has potent anti-viral and anti-inflammatory effects on IAV-infected cells via inhibition of the NF-κB pathway, and could be a potential therapeutic agent for the treatment of influenza.
71
β-sitosterol ameliorates influenza A virus-induced proinflammatory response and acute lung injury in mice by disrupting the cross-talk between RIG-I and IFN/STAT signaling.
Beixian Zhou,Jing Li,Xiaoli Liang,Xiping Pan,Yanbing Hao,Peifang Xie,Haiming Jiang,Zifeng Yang,Zifeng Yang,Nanshan Zhong,Nanshan Zhong +10 more
TL;DR: It is demonstrated that β-sitosterol dose-dependently suppresses inflammatory response through NF-κB and p38 mitogen-activated protein kinase (MAPK) signaling in influenza A virus-infected cells and protects mice from lethal IAV infection.
Sinensetin suppresses influenza a virus-triggered inflammation through inhibition of NF-κB and MAPKs signalings.
Jiashun Li,Xiang Jie,Xiaoli Liang,Ziyu Chen,Peifang Xie,Xiping Pan,Beixian Zhou,Jing Li +7 more
- 05 May 2020
TL;DR: The results indicated that sinensetin has potential capacity to attenuate IAV-triggered pro-inflammatory response via inactivation of NF-κB, ERK1/2 MAPK and p38 MAPK signalings, which implied that sinENSetin may be a promising candidate drug for influenza H1N1 virus infection therapeutics.
(+)‑pinoresinol‑O‑β‑D‑glucopyranoside from Eucommia ulmoides Oliver and its anti‑inflammatory and antiviral effects against influenza A (H1N1) virus infection
Jing Li,Xiaoli Liang,Beixian Zhou,Xiaowei Chen,Peifang Xie,Haiming Jiang,Zhi-Hong Jiang,Zifeng Yang,Xiping Pan +8 more
TL;DR: The data obtained suggest that (+)‑pinoresinol‑O‑β‑D‑glucopyranoside may be a candidate drug for treating influenza H1N1 virus infection.
Patent
Application of erucic acid in preparing medicine for preventing or treating vaccinum influenzae vivum
Yang Zifeng,Li Jing,Xiaoli Liang,Beixian Zhou,Pan Xiping,Zhong Nanshan +5 more
- 11 May 2018
TL;DR: In this paper, a liquid chip technology is adopted to prove that the erucic acid can remarkably inhibit the abnormal expression of an H1N1 virus infected A549 cell inflammatory factor and is in a dose-dependent relationship.